Capital Asset Advisory Services LLC Vertex Pharmaceuticals Inc Transaction History

Capital Asset Advisory Services LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$234.96 - $292.55 $213,578 - $265,927	-909 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$221.42 - $260.97 $201,270 - $237,221	909 New	909 $237,000
Q2 2021 Aug 06, 2021	SELL	$187.49 - $221.1 $224,613 - $264,877	-1,198 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$207.02 - $241.31 $153,608 - $179,052	742 Added 162.72%	1,198 $257,000
Q4 2020 Mar 02, 2021	BUY	$207.01 - $276.09 $94,396 - $125,897	456 New	456 $108,000

1,724

221M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Capital Asset Advisory Services LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Asset Advisory Services LLC with notifications on news.